Pfizer: Pfizer Mounts Defense of Cardiac Blockbuster as Alnylam, BridgeBio Enter Market
Alnylam and BridgeBio are competing for people who are switching from Pfizer's blockbuster ATTR amyloidosis drug tafamidis while all three companies are fighting for new patients.
Read full article »
Pfizer is a New York-based pharmaceutical company that develops and commercializes medicines and vaccines for the healthcare industry.
Read more